Latest Competition News

Immutep reports promising Phase I results for IMP761, a novel LAG-3 agonist antibody demonstrating significant T cell inhibition and a clean safety profile, advancing hopes for new autoimmune disease treatments.

Activeport Group has launched its version 3.0 GPU orchestration software, enabling a major expansion in cloud gaming capacity with a large-scale deployment supporting Radian Arc and Jio’s gaming platforms.

Ausgold Limited has secured a farm-in agreement to acquire up to 70% of a highly prospective exploration license adjacent to its Kulin Gold Project, setting the stage for drilling in FY26 to unlock new gold targets.

Magnum Mining and Exploration Limited reminds eligible shareholders that its non-renounceable entitlement offer closes on 24 June 2025, aiming to raise over $2.2 million to support its strategic growth plans.

Shift4 Payments, LLC has entered into a definitive scheme implementation agreement to acquire Smartpay Holdings Limited at NZ$1.20 per share, subject to regulatory and shareholder approvals. The transaction outlines a detailed timetable and conditions, including Overseas Investment Office consent and court sanction.

Smartpay Holdings has entered a definitive agreement to be acquired by US-based Shift4 Payments for NZ$1.20 per share, representing a significant premium and a near NZ$300 million valuation. The deal, recommended unanimously by Smartpay’s board, awaits shareholder and regulatory approvals.

PointsBet Holdings has highlighted that Betr Entertainment’s proposed takeover offer undervalues its shares compared to MIXI Australia’s superior $1.20 cash bid, intensifying the takeover battle.

betr Entertainment has unveiled a compelling all-scrip takeover offer for PointsBet, featuring an $80 million selective buy-back to provide liquidity and promising significant value creation for shareholders.

AML3D has opened a cutting-edge Wire-Arc Additive Manufacturing facility in Ohio, enhancing U.S. defense production and supporting the AUKUS partnership. The new site aims to supply critical components for the Virginia-class submarine program while creating local jobs.

Zoono Group Limited has announced a pro rata non-renounceable rights issue aiming to raise approximately $1.78 million at $0.035 per share. The capital raise will support shelf-life extension projects, repay related party debt, and bolster working capital.

Argenica Therapeutics has won up to $1.5 million in non-dilutive government funding to support its late-stage clinical trial of ARG-007, a promising treatment for acute ischaemic stroke.

Zoono Group Limited is raising nearly $1.8 million through a non-renounceable rights issue to fund its supermarket shelf-life extension project in Asia and reduce related party debt.